The Goldman Sachs Group Lowers Payoneer Global (NASDAQ:PAYO) Price Target to $7.00
Payoneer Global (NASDAQ:PAYO – Free Report) had its price target decreased by The Goldman Sachs Group from $8.00 to $7.00 in a research note released...
Xcel Brands (NASDAQ:XELB) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Xcel Brands (NASDAQ:XELB – Free Report) in a research note published on Thursday. The firm issued a sell rating...
The Goldman Sachs Group Boosts Core & Main (NYSE:CNM) Price Target to $38.00
Core & Main (NYSE:CNM – Free Report) had its price objective increased by The Goldman Sachs Group from $34.00 to $38.00 in a report issued...
Avantor (NYSE:AVTR) Given New $26.00 Price Target at The Goldman Sachs Group
Avantor (NYSE:AVTR – Free Report) had its price objective boosted by The Goldman Sachs Group from $23.00 to $26.00 in a research note released on...
Neurocrine Biosciences’ (NBIX) “Buy” Rating Reaffirmed at Canaccord Genuity Group
Canaccord Genuity Group reissued their buy rating on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a report published on Thursday, Benzinga reports. Canaccord...
KORU Medical Systems (NASDAQ:KRMD) Stock Rating Reaffirmed by Canaccord Genuity Group
Canaccord Genuity Group reiterated their buy rating on shares of KORU Medical Systems (NASDAQ:KRMD – Free Report) in a research note published on Thursday, Benzinga...